Pamela Strissel: Immunotherapy with a Focus on Bladder Cancer
Speaker: Pamela L. Strissel, Institute of Pathology and Department of Obstetrics and Gynecology, University of Erlangen, Germany
Chair: Carmen Villmann,
Institut für Klinische Neurobiologie, Universitätsklinikum Würzburg
Organizers: Study Group Molecular Medicine
Pamela Strissel received her Ph.D. at the University of Chicago, IL, USA and moved in 2002 to Germany to establish at the FAU Erlangen-Nürnberg a laboratory of Molecular Medicine. Since 2002, she is working at the University Hospital in the Department of Obstetrics and Gynecology. She started out her research career in leukemia research and continued with excellent contributions to 1) the role of human endogenous retroviruses (ERV) in tumorigenesis and placentogenesis, 2) gene and protein deregulation of the PI3K/AKT/mTOR signaling in spontaneous endometrial carcinoma and therapy-induced endometrial carcinoma by tamoxifen of breast cancer patients, 3) unraveling the molecular biology of the benign disease endometriosis, 4) the identification of genes responsible for the rare developmental Mayer-Rokitanski-Küster-Hauser Syndrome (MRKH). Today, she will share with us her recent data on a project together with the Department of Pathology at the University Hospital Erlangen on immunotherapy in bladder cancer.